Drug intelligence / Profile preview

CaMC-LP

Development stage
Preclinical
Modality
Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01

Overview

CaMC-LP is a liposomal encapsulated formulation of the chloroform fraction (CaMC) derived from the bark of *Cassia fistula* L., commonly known as the Golden shower tree. This phytopharmaceutical candidate contains bioactive constituents, including piperine, which exhibit potent anticancer activity. The mechanism of action involves the induction of apoptosis through the upregulation of pro-apoptotic markers such as p53, caspase 3, and caspase 9, and the downregulation of the anti-apoptotic protein Bcl-2. Additionally, it induces cell cycle arrest at the G0/G1 phase. Liposomal encapsulation enhances the delivery and efficacy of the chloroform fraction, demonstrating significant tumor growth inhibition in Ehrlich Ascites Carcinoma (EAC) models compared to the non-encapsulated fraction, with a profile comparable to 5-Fluorouracil but without inducing significant toxicity.

Other names
liposomal encapsulated chloroform fraction of Cassia fistula L. barkliposomal CaMC
02

Targets

BCL-2 (BCL-2 family)CASP9 (Caspase-9)TP53 (Cellular Tumor Antigen p53 R175H)CASP3 (Caspase-3)

Beyond the preview

Go deeper on CaMC-LP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CaMC-LP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call